Literature DB >> 3014086

Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.

T E Hilditch, J M Connell, A T Elliot, T Murray, N S Reed.   

Abstract

The value of [99mTc(V)]DMS and [131I]MIBG in imaging medullary carcinoma of the thyroid was investigated in five patients. Results with [99mTc(V)]DMS were negative in all five patients as well as with [131I]MIBG in four patients; however, there was significant tumor uptake in one patient with [131I]MIBG.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014086

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

1.  (131I)meta-iodobenzylguanidine scintigraphy and selective venous catheterization after thyroidectomy for medullary thyroid carcinoma.

Authors:  G Lupoli; G Lombardi; N Panza; B Biondi; G Pacilio; S Lastoria; M Salvatore
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

2.  The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.

Authors:  L Troncone; V Rufini; P Montemaggi; F M Danza; A Lasorella; R Mastrangelo
Journal:  Eur J Nucl Med       Date:  1990

3.  Accumulation of thallium-201 in medullary thyroid cancer with negative serum calcitonin and carcinoembryonic antigens: a case report.

Authors:  M Koizumi; T Watari; K Hirabayashi
Journal:  Ann Nucl Med       Date:  1993-02       Impact factor: 2.668

4.  Medullary thyroid carcinoma mimicking an autonomous functioning nodule.

Authors:  I Rivas; C Gutiérrez; J Vendrell; S Razkin; C Richart
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

5.  Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma.

Authors:  Rafał Czepczyński; Maria Gemma Parisella; Jerzy Kosowicz; Renata Mikołajczak; Katarzyna Ziemnicka; Maria Gryczyńska; Jerzy Sowiński; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-26       Impact factor: 9.236

6.  Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis.

Authors:  M C Patel; R B Patel; P Ramanathan; N Ramamoorthy; B A Krishna; S M Sharma
Journal:  Eur J Nucl Med       Date:  1988

7.  Thyroid uptake of MIBG in Sipple's syndrome.

Authors:  R Perdrisot; V Rohmer; J J Lejeune; J C Bigorgne; P Jallet
Journal:  Eur J Nucl Med       Date:  1988

8.  Pitfalls in scintigraphic detection of neuroendocrine tumours.

Authors:  L Feggi; E Degli Uberti; G C Pansini; G Transforini; N Prandini; M R Ambrosio; A R D'Urso; R Faggioli
Journal:  Eur J Nucl Med       Date:  1992

9.  Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma.

Authors:  P Magnani; G Paganelli; C Songini; A Samuel; F Sudati; A G Siccardi; F Fazio
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.